Download PDF
CC BY 4.0 · Journal of Health and Allied Sciences NU 2024; 14(02): 290-293
DOI: 10.1055/s-0043-1769583
Case Report

Mucormycosis of the Middle Ear—A Report of a Rare Case

Megha Madhu
1   Department of ENT, KS Hegde Medical Academy, Mangalore, Karnataka, India
,
Shrinath D. Kamath P
1   Department of ENT, KS Hegde Medical Academy, Mangalore, Karnataka, India
,
Vadisha Bhat
1   Department of ENT, KS Hegde Medical Academy, Mangalore, Karnataka, India
,
Teerthanath Srinivas
2   Department of Pathology, KS Hegde Medical Academy, Mangalore, Karnataka, India
› Author Affiliations
› Further Information
Also available at
  Permissions and Reprints

Abstract

Mucormycosis is an opportunistic fungal infection that often affects the nose and paranasal sinuses. The disease prevalence was very high in India during the coronavirus disease 2019 pandemic, thereby raising public awareness about this disease. The general practitioners were updated about the disease characteristics and the requirement for emergency management. Yet, in some instances, the treatment was inadequate due to delayed presentation and low affordability for treatment. The mucormycosis of the ear, on the other hand, is a rare occurrence that demands meticulous study for early diagnosis and management. Here, we discuss the case of a patient with mucormycosis of the middle ear.

Keywords

mucormycosis - middle ear - diabetic - facial palsy


Publication History

Article published online:
19 June 2023

© 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Kermani W, Bouttay R, Belcadhi M, Zaghouani H, Ben Ali M, Abdelkéfi M. ENT mucormycosis. Report of 4 cases. Eur Ann Otorhinolaryngol Head Neck Dis 2016; 133 (02) 83-86
    CrossrefPubMedSearch in Google Scholar
  • 2 Riley TT, Muzny CA, Swiatlo E, Legendre DP. Breaking the mold: a review of mucormycosis and current pharmacological treatment options. Ann Pharmacother 2016; 50 (09) 747-757
    CrossrefPubMedSearch in Google Scholar
  • 3 Steinbrink JM, Miceli MH. Mucormycosis. Infect Dis Clin North Am 2021; 35 (02) 435-452
    CrossrefPubMedSearch in Google Scholar
  • 4 Biniyam K, Bhat V, Bhandary SB, Aroor R. Asymptomatic mucormycosis of middle ear: an incidental finding during tympanoplasty. Indian J Otol 2014; 20: 83-85
    CrossrefSearch in Google Scholar
  • 5 Hassan MIA, Voigt K. Pathogenicity patterns of mucormycosis: epidemiology, interaction with immune cells and virulence factors. Med Mycol 2019; 57 (Suppl. 02) S245-S256
    CrossrefPubMedSearch in Google Scholar
  • 6 Ibrahim AS, Gebermariam T, Fu Y. et al. The iron chelator deferasirox protects mice from mucormycosis through iron starvation. J Clin Invest 2007; 117 (09) 2649-2657
    CrossrefPubMedSearch in Google Scholar
  • 7 Gebremariam T, Liu M, Luo G. et al. CotH3 mediates fungal invasion of host cells during mucormycosis. J Clin Invest 2014; 124 (01) 237-250
    CrossrefPubMedSearch in Google Scholar
  • 8 Spreer A, Rüchel R, Reichard U. Characterization of an extracellular subtilisin protease of Rhizopus microsporus and evidence for its expression during invasive rhinoorbital mycosis. Med Mycol 2006; 44 (08) 723-731
    CrossrefPubMedSearch in Google Scholar
  • 9 Patiño-Medina JA, Maldonado-Herrera G, Pérez-Arques C. et al. Control of morphology and virulence by ADP-ribosylation factors (Arf) in Mucor circinelloides. Curr Genet 2018; 64 (04) 853-869
    CrossrefPubMedSearch in Google Scholar
  • 10 Bhansali A, Bhadada S, Sharma A. et al. Presentation and outcome of rhino-orbital-cerebral mucormycosis in patients with diabetes. Postgrad Med J 2004; 80 (949): 670-674
    CrossrefPubMedSearch in Google Scholar
  • 11 Charfi S, Ayadi L, Makni S. et al. Rhinocerebral mucormycosis: anatomoclinical study of seventh cases. J Mycol Med 2008; 18: 46-52
    Search in Google Scholar
  • 12 Spellberg B, Edwards Jr J, Ibrahim A. Novel perspectives on mucormycosis: pathophysiology, presentation, and management. Clin Microbiol Rev 2005; 18 (03) 556-569
    CrossrefPubMedSearch in Google Scholar
  • 13 Rogers TR. Treatment of zygomycosis: current and new options. J Antimicrob Chemother 2008; 61 (Suppl. 01) i35-i40
    CrossrefPubMedSearch in Google Scholar
  • 14 Kim JG, Park HJ, Park JH. et al. Importance of immediate surgical intervention and antifungal treatment for rhinocerebral mucormycosis: a case report. J Korean Assoc Oral Maxillofac Surg 2013; 39 (05) 246-250
    CrossrefPubMedSearch in Google Scholar
  • 15 Almannai M, Imran H, Estrada B, Siddiqui AH. Successful treatment of rhino-orbital mucormycosis with posaconazole and hyperbaric oxygen therapy. Pediatr Hematol Oncol 2013; 30 (03) 184-186
    CrossrefPubMedSearch in Google Scholar
  • 16 Yun MW, Lui CC, Chen WJ. Facial paralysis secondary to tympanic mucormycosis: case report. Am J Otol 1994; 15 (03) 413-414
    PubMedSearch in Google Scholar
  • 17 Macdonell RA, Donnan GA, Kalnins RM, Richards MJ, Bladin PF. Otocerebral mucormycosis–a case report. Clin Exp Neurol 1987; 23: 225-232
    PubMedSearch in Google Scholar
  • 18 Hazarika P, Ravikumar V, Nayak RG, Roa PS, Shivnanda PG. Rhinocerebral mucormycosis. Ear Nose Throat J 1984; 63: 100-106
    Search in Google Scholar